📰 Pals News
Page 95 - Pals News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pals. Real-time updates on events, politics, business and more.
September 25, 2023
The FDA is meeting this week to consider NurOwn, a much-debated treatment for Lou Gehrig’s disease. The agency says the treatment hasn't been shown to work.
September 25, 2023
The FDA is meeting this week to consider NurOwn, a much-debated treatment for Lou Gehrig’s disease. The agency says the treatment hasn't been shown to work.
September 25, 2023
The FDA is meeting this week to consider NurOwn, a much-debated treatment for Lou Gehrig’s disease. The agency says the treatment hasn't been shown to work.
September 24, 2023
An event at Day Air Ballpark on Sunday aimed to raise money and awareness about ALS, also known as Lou Gehrig's disease.
September 20, 2023
Elon Musks Neuralink has gained approval to begin its first human clinical trial for its brain-computer interface implant. Known as the "PRIME Study," the trial aims to evaluate the safety and functionality of Neuralinks implant and surgical robot. The goal is to enable individuals with paralysis to control external devices using their thoughts. This milestone follows the FDAs previous refusal to allow Neuralink to implant a brain chip in humans.
September 20, 2023
Sola Coffee in North Raleigh is renowned for its commitment to quality and they offer a cup of coffee thats not just delicious but also brewed with a conscience.
September 20, 2023
It was a cool, or shall we say cold, way to raise money: Jacksonville leaders took an icy dip to raise money for the ALS Association.
September 20, 2023
Huntsville, 20, 2023 - Steadright Critical Minerals is pleased to provide an update on Steadright's exploration team efforts with its Summer/Fall exploration program on the highly prospective RAM project near Port Cartier, , which is associated with... - Veroeffentlicht am 20.09.2023
September 19, 2023
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
September 19, 2023
Ryan Haumschild, PharmD, MS, MBA, director of pharmacy at Emory Winship Cancer Institute, shares his unique perspectives as both a provider and payer on the use of prior authorizations (PAs) and "Gold Cards" in patients with rare diseases.